Literature DB >> 1525844

Markers of bone and collagen breakdown in early inflammatory arthritis.

N Peel, R Eastell, G Russell.   

Abstract

Inflammatory arthritis has the potential to cause irreversible erosive damage to cartilage and bone. This may occur very early in the course of the disease. At present it is not possible at diagnosis to identify those patients who will develop erosive damage. If this were possible, it would enable aggressive therapy to be targeted to those patients at greatest risk. There is therefore a need for sensitive markers to detect and quantify joint damage at as early a stage as possible. In this chapter we review potential biochemical markers of such damage and assess their clinical usefulness.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525844     DOI: 10.1016/s0950-3579(05)80179-7

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  5 in total

1.  Increased type I collagen degradation is associated with a need for total joint replacement surgery in rheumatoid arthritis.

Authors:  S Aman; M Hakala; L Risteli; J Risteli
Journal:  Ann Rheum Dis       Date:  1996-02       Impact factor: 19.103

2.  Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction.

Authors:  B Månsson; P Geborek; T Saxne
Journal:  Ann Rheum Dis       Date:  1997-02       Impact factor: 19.103

3.  The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study.

Authors:  S Aman; J Risteli; R Luukkainen; L Risteli; M Kauppi; P Nieminen; M Hakala
Journal:  Ann Rheum Dis       Date:  1999-09       Impact factor: 19.103

4.  Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis.

Authors:  M Hakala; L Risteli; J Manelius; P Nieminen; J Risteli
Journal:  Ann Rheum Dis       Date:  1993-12       Impact factor: 19.103

5.  Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis.

Authors:  M Hakala; S Aman; R Luukkainen; L Risteli; M Kauppi; P Nieminen; J Risteli
Journal:  Ann Rheum Dis       Date:  1995-11       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.